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One way to determine rate of percutaneous
absorption is dose-response comparisons following
this mode of administration and intravenous
infusion. This method has been discussed in
detail by Fredriksson (1) and Griesemer et at.
(2) in connection with measurements of the rate
of absorption of an organophosphorus eholines-
terase inhibitor, sarin. The last-mentioned
authors chose inhibition of blood eholinesterase
activity in the rabbit as a basis for the dose-
response comparison. It was decided to use the
same parameter in connection with the two
routes of administration in order to determine
the rate of percutaneous absorption of paraoxon,
a compound that belongs to the same phar-
macologic group as sarin, but to modify the
technic in several respects in order to improve
the accuracy. Thus, the eat was selected as
experimental animal, since this species has
higher plasma eholinesterase activity than the
rabbit. A higher activity makes the individual
determinations of enzyme activity more accurate.
Furthermore, it was decided to adjust the rate of
infusion so that it corresponded as closely as
possible to the rate of percutaneous absorption,
since the distribution of organophosphorus com-
pounds, their detoxification and, thus, the pro-
portion available for enzyme inhibition is
dependent on the rate of systemic administration
(see review by Holmstedt, 3). Since there obvi-
ously must be a latency period before the topically
applied material will reach the blood stream and
produce inhibition of the enzyme activity, an
adjustment of the rate of infusion so that the
degree of enzyme inhibition after a given interval
is the same as the degree of inhibition after the
same interval following percutaneous application
by necessity must result in too low values con-
cerning the rate of percutaneous absorption.
This potential error may be increased also if
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single measurements of enzyme activity are used
because of their relative inaccuracy. 'I'herefore,
it was decided to adjust the rate of infusion so
that the rate of enzyme inhibition was the same
as following topical application. This makes
corrections for the hypothetical latency period
unnecessary, and the slope of the inhibition
curve, determined by several measurements of
activity, can be used as basis for the comparison
instead of single and, therefore, uncertain activity
values. Finally, in order to diminish errors due
to variations in blood volume and, thus, absolute
amount of enzymes present it was decided to use
animals of as uniform weight as the stock
permitted.
METHODs
Paraoxon (E 600, or diethyl 4-nitrophenyl
phosphate) was supplied by Mallinckrodt
Chemical Works, St. Louis, Mo. When tested
for purity with the aid of paper chromatography
(4), it was found to contain only traces of p-
nitrophenol.
Twelve cats, weighing between 2.6 and 3.0 kg,
were used. They were anesthetized with sodium
pentobarbital, 25 mg per kg body weight, ad-
ministered intraperitoneally. In all the animals,
the trachea and one carotid artery were can-
nulated. Blood samples were taken from the
carotid artery every 30 minutes for 4 to 5 hours.
In the animals used for intravenous infusion,
the left femoral vein was cannulated. In this
case, the paraoxon was dissolved in propylene
glycol, and the rate of infusion was adjusted to
1.0 ml per hour with the aid of an infusion pump.
The concentration of paraoxon was varied be-
tween 128 and 32 pg per ml. In the animals used
for percutaneous absorption, 50 p1 of undiluted
paraoxon was evenly distributed over 4.1 em2
on a clipped area on the lateral aspect of the left
thigh, as described earlier (5). Plasma was sepa-
rated by centrifugation, and the enzyme activity
was determined with the Warburg technic, using
aeetyleholine as substrate. The activity values,
expressed as percentage of the 0-time value, were
plotted in a semi-logarithmic system as ordinates
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Fin. 1. Inhibition of plasma cholinesterase activity in five cats following cutaneous application (open
circles) of 50 pl of paraoxon on 4.1 cm', and following intravenous infusion (filled circles) of paraoxon.
The rates of infusion were 64 pg per hour (lower curve) and 32 pg per hour (upper curve). Time is in
minutes after beginning of administration.
against time When plotted, the values whree.
the inhibition approached asymptotic regions
were omitted, and the 0-time value was omitted
also because the latency period must be taken
into account. In order to compare the slopes of
the curves, the velocity constant of the inhibition
of the enzyme activity was derived from the
conventional formula.
A1 = A,
RESULTS AND DISCUSSION
Cholinergic signs, such as salivation, miosis
and fasciculations in different muscles, appeared
occasionally in both groups of animals. The only
local symptom following percutaneous absorp-
tion was fasciculations in the muscles underlying
the area of application; this sign usually appeared
one hour from application.
Both forms of administration resulted in
inhibition curves, which followed straight lines
when plotted in a semi-logarithmic system, as
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TABLE 1
The first order reaction velocity constant of the
inhibition of plasma cholinesterase activity
fotlowing intravenous infusion and percutaneous
absorption of paraoxon in the cat
(1)
where A1 is the activity at an arbitrary point of
time (t1), A, the initial activity (at time t,) and
k the velocity constant. The constant Ic was
calculated from the following linear transfornia-
tion of equation (1):
h log As—log A1 2—
0.4343(t1 — t,)
Form of admiois-
tration
Intravenous
infusion
Dosage
32 pg hr'
32
64
64
Velocity coo-
staot S min'
0.0036
0.0045
0.0160
0.0180
Percutaneous
absorption
50 pl on 4.1 cm'
50
50
50
50
50
0.0053
0.0078
0.0092
0.0098
0.0110
0.0140
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shown by representative curves in Fig. 1. Since
it is a well known fact that the inhibition of
cholinesterases by paraoxon is a first order
reaction, the form of the curves means that the
rate of percutaneous absorption is constant in a
given skin when conditions such as temperature
remain constant. This result confirms findings
obtained in vitro (6) and in vivo (1) in studies of
the percutaneous absorption of sarin.
All the inhibition curves obtained in the six
cats used for percutaneous absorption fell within
a range, which corresponded to intravenous
infusion rates of 32 to 64 pg per hour. Two
representative inhibition curves obtained with
these infusion rates appear in Fig. 1 together with
three representative curves obtained in experi-
ments with percutaneous absorption. The velocity
constants are given in Table 1. The rates of
percutaneous absorption of active paraoxon into
the blood stream can be calculated easily from
these velocity constants. The absorption rates
were approximately 0.13 to 0.26 pg mm em2, or
0.47 to 0.95 mpM mm .em2. It must be remem-
bered that these values represent only the rate
of absorption of active inhibitor into the blood
stream.
The disappearance rate from the topical deposit
might be considerably higher than the absorption
rate, since part of the material may be detoxified
during diffusion through the skin. In an earlier
investigation (4), it was shown that eat skin
contains an enzyme that is capable of hydrolyz-
ing paraoxon. Those results indicated that cat
skin was capable of splitting approximately 30
pg paraoxon per hour and gram of tissue (1 g of
cat skin equals 12—15 cm2) at 25°C, a value which
does not represent optimal activity due to the
thickness of the slices and to the fact that it was
not measured at body temperature. In earlier
experiments (1) with sarin, it appeared that
approximately 90 per cent of this compound was
inactivated before it reached the blood stream,
and the inactivation of paraoxon might be of the
same order of magnitude.
The present method of plotting the activity
values makes it possible to determine the latency
period mentioned earlier by extrapolation of the
curves to the 100 per cent level (the broken line
in Fig. I). Following intravenous infusion, there
was a latency period of 10 to 15 minutes; this
period probably represents both the time neces-
sary to build up a concentration of inhibitor
high enough to produce any inactivation of the
enzyme activity and the lag period due to the
circulation of the blood. Following percutaneous
absorption, the latency period was found to be
20 to 28 minutes. The difference between the
latency period following percutaneous absorption
and the one following intravenous infusion
represents, thus, the actual time it takes the
material to diffuse from the topical deposit to the
blood stream. When curves with approximately
equal slopes were chosen from both groups, the
difference was found to be approximately 12
minutes. Griesemer et at. (2) have assumed
that the latency period in the ease of sarin is 15
minutes, a period of time which seems reasonable
in view of the evidence given above.
SUMMARY
The rate of percutaneous absorption of
paraoxon (E 600, or diethyl 4-nitrophenyl
phosphate) has been determined by dose-response
comparison following this mode of administration
and intravenous infusion in the eat. The rate of
inhibition of plasma cholinesterase activity was
chosen as the parameter. The enzyme activity
values were plotted in a semi-logarithmic system
as ordinates against time. Under the conditions
of the study, the rate of percutaneous absorption
was found to be constant in a given skin. The
rate varied between 0.13 to 0.26 pg mm cm2
(0.47 to 0.95 mpM mm cm2). These values rep-
resent only the absorption of active material
into the blood stream. The disappearance rate
from the topical deposit may be considerably
higher, since there are enzymes present in eat
skin capable of hydrolyzing paraoxon. By extra-
polation from the activity curves, it was possible
to determine the time required for paraoxon to
diffuse from the topical deposit to the blood
stream. This latency period was found to be
approximately 12 minutes.
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